IACH News Podcasts

Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access.

May 8th- Beyond the webinar: Multiple Myeloma in 2026: Innovation Meets Reality – Lessons from the Australian Experience

CME Congresses .

May 8th- Beyond the webinar: Multiple Myeloma in 2026: Innovation Meets Reality – Lessons from the Australian Experience

May 7th- Beyond the webinar: Busulfan in Hematology – From Empiricism to Precision Conditioning

CME Congresses .

May 7th- Beyond the webinar: Busulfan in Hematology – From Empiricism to Precision Conditioning

May 4th- Reinventing Drug Delivery in Multiple Myeloma: The Rise of the On-Body Injector for Isatuximab

CME Congresses .

May 4th- Reinventing Drug Delivery in Multiple Myeloma: The Rise of the On-Body Injector for Isatuximab

May 1st- Beyond the Webinar: CAR-T Cells- From Breakthrough to Global Transformation

CME Congresses .

May 1st- Beyond the Webinar: CAR-T Cells- From Breakthrough to Global Transformation

May 5th- Dr. Neta Nevo- Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel

CME Congresses .

May 5th- Dr. Neta Nevo- Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel

April 27th- Prof. Robert Zeiser- Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML

CME Congresses .

April 27th- Prof. Robert Zeiser- Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML

April 22nd- Hepta-Refractory Myeloma: When Targets Disappear

CME Congresses .

April 22nd- Hepta-Refractory Myeloma: When Targets Disappear

April 20th- Beyond the webinar: Non-Transfusion-Dependent Thalassemia: From Observation to Intervention

CME Congresses .

April 20th- Beyond the webinar: Non-Transfusion-Dependent Thalassemia: From Observation to Intervention

April 13th- Dr. Florian Simon- Acalabrutinib treatment for older (aged ≥80 years) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial

CME Congresses .

April 13th- Dr. Florian Simon- Acalabrutinib treatment for older (aged ≥80 years) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial

April 9th- Beyond the Webinar: EBMT 2026- From Innovation to Clinical Impact

CME Congresses .

April 9th- Beyond the Webinar: EBMT 2026- From Innovation to Clinical Impact